Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Recalcitrant nongenital warts.

Literature DB >> 21301692

Recalcitrant nongenital warts.

Abstract

Nongenital warts are a common presentation in general practice. Despite treatment according to evidence based guidelines, a significant proportion of common warts fail to resolve, becoming recalcitrant. This poses a problem in clinical management. The recommendations for treating recalcitrant warts are unclear and there is a wide range of second line treatments available. This article reviews the available methods of treatment for recalcitrant nongenital warts as described in the medical literature.

Mesh：

Substances：

Year: 2011 PMID： 21301692

Source DB: PubMed Journal: Aust Fam Physician ISSN： 0300-8495

Keyword Cloud
Cited

11 in total

1. Topical 15% Zinc Oxide Ointment Significantly Reduces the Size of Common Warts After Four Weeks: A Randomized, Triple-blinded, Placebo-controlled Trial.

Authors: Chankiat Songsantiphap; Pravit Asawanonda
Journal: J Clin Aesthet Dermatol Date: 2019-09-01

2. Therapeutic Outcome of Intralesional Immunotherapy in Cutaneous Warts Using the Mumps, Measles, and Rubella Vaccine: A Randomized, Placebo-controlled Trial.

Authors: Guneet Awal; Simplepreet Kaur
Journal: J Clin Aesthet Dermatol Date: 2018-05-01

Review 3. Consideration of underlying immunodeficiency in refractory or recalcitrant warts: A review of the literature.

Authors: J Zampella; B Cohen
Journal: Skin Health Dis Date: 2022-02-09

Review 4. Warts and all: human papillomavirus in primary immunodeficiencies.

Authors: Jennifer W Leiding; Steven M Holland
Journal: J Allergy Clin Immunol Date: 2012-10-01 Impact factor: 10.793

5. Recalcitrant Cutaneous Warts in a Family with Inherited ICOS Deficiency.

Authors: Leila Youssefian; Amir Hossein Saeidian; Ali Reza Tavasoli; Elnaz Kalamati; Karim Naghipoor; Amir Hozhabrpour; Mehrnaz Mesdaghi; Zahra Saffarian; Hamidreza Mahmoudi; Mohammad Nabavi; Sima Shokri; Sirous Zeinali; Vivien Béziat; Jean-Laurent Casanova; Emmanuelle Jouanguy; Jouni Uitto; Hassan Vahidnezhad
Journal: J Invest Dermatol Date: 2022-03-08 Impact factor: 7.590

Recalcitrant nongenital warts.

1. Topical 15% Zinc Oxide Ointment Significantly Reduces the Size of Common Warts After Four Weeks: A Randomized, Triple-blinded, Placebo-controlled Trial.

2. Therapeutic Outcome of Intralesional Immunotherapy in Cutaneous Warts Using the Mumps, Measles, and Rubella Vaccine: A Randomized, Placebo-controlled Trial.

Review 3. Consideration of underlying immunodeficiency in refractory or recalcitrant warts: A review of the literature.

Review 4. Warts and all: human papillomavirus in primary immunodeficiencies.

5. Recalcitrant Cutaneous Warts in a Family with Inherited ICOS Deficiency.

6. Mucocutaneous warts in Middle Anatolia, Turkey: clinical presentations and therapeutic approaches.

7. Intralesional Immunotherapy with Measles-Mumps-Rubella Vaccine for Recalcitrant Facial Warts: A Report of Two Cases.

8. HPV Vaccination Status and Resolution of Warts in Pediatric Patients.

9. Hyfrecation for recalcitrant nongenital warts.

10. The Application of Machine Learning in Predicting Outcome of Cryotherapy and Immunotherapy for Wart Removal.